Page 30 - Pharmaceutical Firms

Zydus supplies first batch of 30,000 Covid Kavach Elisa tests to ICMR

Robust antibody tests are critical for surveillance and understanding the proportion of the population exposed to SARS Cov-2 infection

Britain's AstraZeneca to make bn Covid-19 vaccine doses if tests succeed

Drugmaker says it had signed the first agreements to supply at least 400 million doses of the vaccine, which it is developing with Oxford University.

Strides Pharma to conduct trials for potential Covid-19 drug Favipiravir

Favipiravir is manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug in the country in 2014

Pfizer to outsource some drug production, focus on coronavirus vaccine

Pfizer and German partner BioNTech SE (22UAy.F) said on Tuesday they have begun delivering doses of their coronavirus vaccine candidates for initial human testing in the United States.

Mumbai docs try Biocon and Roche's biologic drugs on critical Covid cases

Two repurposed drugs for rheumatoid arthritis and psoriasis are being tried on over 100 patients in Mumbai

Vaccinating policy

IP regimes should not outweigh public health interests

Patents vs the pandemic

We should question the wisdom and morality of a system that silently condemns millions of human beings to suffering

Pharma traders seek IT rule exemption as retailers pay stockists in cash

They fear scrutiny by tax authorities at a later date, assure that the relaxation will not be misused

Investors should stick to stocks of firms focused on domestic market

Pharma firms can build brands and enjoy higher margins here

Covid-19: 26 Navy sailors test positive; no cases on combat ships

India tally nears 15,000-mark

Drug regulator asks traders to stock 55 ICU drugs for Covid-19 treatment

These drugs are in addition to the requirement to hydroxychloroquine and Azithromycin for patients, healthcare workers and household contacts of positive cases

Race for vaccine against coronavirus heats up in India; 6 firms in the fray

With vaccines of some firms already in the animal trial phase, developers say that if all goes well, India can have a vaccine by next year, ahead of the earlier timelines

India's only quinine making unit set up in 1874, has been shut since 2001

Covid-19 has triggered a sense of urgency to revive this sick unit, as Hydroxychloroquine, an anti-malarial drug, surfaced as potential medicine to alleviate the symptoms of the disease

Aurobindo terminates $900-million Sandoz product acquistion deal

A mutual decision to cancel the agreement was taken as approval from US Federal Trade Commission was not obtained within anticipated timelines

Clinical trial norms may be eased for developing coronavirus vaccine

Sources said no fresh approvals would be given for clinical trials, except for those related to Covid-19.

Big Pharma's addiction to profit

Book review of PHARMA: Greed, Lies, and the Poisoning of America

The post-COVID-19 world

Policymakers and pharma companies will have to work together to speed up trials of new vaccines and legislate to ensure essential drugs and tests are affordable and available

Coronavirus impact: Govt keeps close tabs on drug supply, pricing

Govt keeping tabs on raw material stock, prices, and helping firms airlift APIs

Laudable move by Pharmexcil

The Pharmexcil came up with clarifications for its members and representations to the government highlighting some difficulties

Coronavirus: Govt to consider airlifting APIs only if industry pays

Due to Coronavirus outbreak in China, supply of pharmaceutical goods and components are being delayed